Integra LifeSciences Holdings Corporation (IART:NASDAQ) closed at $14.40 on November 13, 2026, up 0.35% on the day. The stock trades 29.7% below its 52-week high of $20.49 and 65.5% above its 52-week low of $8.70. Over the past year, it gained 22.6%. Integra LifeSciences Holdings Corporation is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 13, 2025, IART closed higher on 133 days (53%). Its best day was May 5, 2026 (+24.13%) and its worst was October 2, 2026 (-21.19%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates through two segments, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle...
Find more stocks like IART with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.